Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1590 of 5804
-
Gum treatment may boost artery function in periodontitis patients
Disease control CompletedA double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment on endothelial dysfunction parameters in subjects with periodontitis and without any cardiovascular disease.
Phase: NA • Sponsor: University of Catania • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug shows promise in slowing lung scarring
Disease control CompletedA placebo-controlled, multicenter, randomized trial to test GKT137831 in ambulatory patients with idiopathic pulmonary fibrosis. This drug is an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) isoforms. The investigators hypothesize the drug will de…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a hybrid surgical technique better remove large bladder tumors?
Disease control CompletedModified en bloc resection is a hybrid technique involving piecemeal resection of the exophytic part of the bladder tumour, followed by en bloc resection of the tumour base. In this study, we shall investigate the efficacy of modified en bloc resection for patients with bladder t…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug aims to tame chemotherapy side effect in young cancer patients
Disease control Recruiting nowThis is a phase I/II clinical trial assessing the tolerability and efficacy of CM4620 in children and young adults with acute pancreatitis caused by asparaginase. The tolerability of CM4620 when given to patients receiving frontline chemotherapy will be determined. The effectiven…
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Cancer drug cocktail shows promise for tough blood cancers, but study halted early
Disease control TerminatedThis phase I/II trial investigates the side effects and best dose of venetoclax when given together with azacitidine and to see how well it works in treating patients with high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia that has come back (relapsed) or has n…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Avastin vs eylea: which eye drug needs fewer shots?
Disease control OngoingThe study investigates whether patients treated for neovascular (wet) age-related macular degeneration (AMD), with intravitreal injection with bevacizumab (Avastin) after two years need more injections with retained therapy response compared to patients being treated with intravi…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Smart algorithm aims to improve heart failure care
Disease control CompletedThe ALLEVIATE-HF study is a prospective, randomized, controlled, blinded, multi-site, interventional, investigational device exemption (IDE) pivotal study. The purpose of the study is to demonstrate the safety and efficacy of a patient management pathway that utilizes an integrat…
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can Botox-Like shots straighten Teens' spines?
Disease control Recruiting nowThis study evaluates the combined effect of botulinum toxin A (administered as Dysport® (Ipsen Pharmaceuticals)) and bracing in children with adolescent idiopathic scoliosis. Two thirds of patients will be treated with Dysport® and bracing, while the remaining patients will be tr…
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New oral drug targets Hard-to-Treat HER2 cancers
Disease control OngoingThis will be a Phase 1, multicenter, open-label trial to evaluate the safety, tolerability, PK and efficacy of ZN-A-1041 as a monotherapy or in combination in participants with HER2-positive advanced solid tumors with or without brain metastases. The study will consist of three …
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Global registry aims to unlock clues for heart transplant success in adults born with heart defects
Knowledge-focused Recruiting nowAdvances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the sur…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Fiber pills may ease radiation side effects for pelvic cancer patients
Symptom relief CompletedThe investigators hypothesize that an increase in dietary fiber intake during radiation therapy may provide better long-term intestinal health for the cancer survivor. If the hypothesis is not correct, the increased intake may only mean an increase in acute side effects. All part…
Phase: PHASE3 • Sponsor: Sahlgrenska University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 15:22 UTC
-
New combo therapy hopes to tackle tough lymphoma
Disease control OngoingThe purpose of this study is to find the highest dose of a new drug, in combination with standard drugs, which can be tolerated without causing very severe side effects. The study treatment is new agents in combination with R-GDP or an equivalent regimen.
Phase: EARLY_PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Knee replacement pain study aims to cut chronic pain risk
Symptom relief CompletedThe prevalence of Chronic Post-Surgical Pain (CPSP) after knee replacement, defined as pain greater than or equal to 4/10 on the visual analogue scale after the third postoperative month, is recognised as high, with an average of 20% (extremes of 7 to 45%). These CPSP, when pres…
Phase: NA • Sponsor: Centre Hospitalier Departemental Vendee • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy shows promise for Radioiodine-Resistant thyroid cancer
Disease control OngoingThe purpose of this study is to find out whether a drug called PDR001, combined with either trametinib or dabrafenib, is a safe and effective treatment for thyroid cancer.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
Symptom relief CompletedIrritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of life. Dietary therapy is considered one of the primary treatment approaches; however, the optimal sequence of dietary interventions remains unclear. This randomiz…
Phase: NA • Sponsor: Antalya Bilim University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for leukemia patients too sick for chemo?
Disease control TerminatedThis trial seeked to extend the preliminary findings of efficacy by evaluating MBG453 in combination with hypomethylating agents (HMA) and also Bcl-2 inhibitor venetoclax.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Blood transfusions after ICU: a new hope for tired survivors?
Symptom relief OngoingOn discharge from intensive care (ICU) patients are often severely anaemic (have a low level of haemoglobin (Hb) in their red blood cells (RBC)). Anaemia can persist for many months making patients feel tired and fatigued. Regaining pre-illness health and energy levels can take a…
Phase: NA • Sponsor: University of Edinburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New vaccine aims to fight breast cancer by training the immune system
⭐️ VACCINE ⭐️ OngoingThis is a phase I study looking at the safety of cancer peptides combined with adjuvant and GM-CSF in subjects with estrogen receptor (ESR) positive breast cancer. The primary objective of the study is to determine the safety of of the peptide vaccine. The secondary objective is …
Phase: PHASE1 • Sponsor: Herbert Lyerly • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Zapping away tremors: scientists probe how electrical stimulation calms shaky hands
Knowledge-focused TerminatedThe purpose of this study is to understand the neurophysiological mechanisms of peripheral electrical stimulation (PES) in modulating supraspinal tremorogenic input to motoneurons. For this purpose, the investigators will use transcutaneous PES, high-density electromyography (HD-…
Phase: NA • Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
AI listens in on 911 calls to catch strokes before It's too late
Knowledge-focused OngoingMore than 12.000 patients suffer acute stroke in Norway every year, but less than half of them reach hospital within the current treatment window for thrombolysis. Stroke is the third-highest cause of death and the number one cause of severe disability requiring long time care at…
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC